The Differential Impact of High-Intensity Swimming Exercise and Inflammatory Bowel Disease on IL-1β, TNF-α, and COX-2 Gene Expression in the Small Intestine and Colon in Mice Immune Activity in Swimming Exercise and IBD

Main Article Content

Eun-Ju Choi
Wi-Young So

Keywords

Abstract

Background and Objective: We aimed to examine the impact of high-intensity swimming exercise and inflammatory bowel disease (IBD) on IL-1β, TNF-α, and COX-2 gene expression in the small intestine and colon of mice.


Material and Methods: Forty male C57BL/6 mice were divided into 4 groups: the control group (CON), swimming exercise group (EX), 50% ethanol (EtoH) control group (50%EtoH CON), and 2,4,6-trinitrobenzene sulfonic acid group (TNBS). The EX group performed 4 weeks of exercise. Intrarectal TNBS injection induced IBD in the TNBS group; the 50%EtoH CON group received control injections. Reverse transcription and real-time polymerase chain reaction were used to examine IL-1β, TNF-α, and COX-2 mRNA expression in the small intestine and colon.


Results: IL-1β, TNF-α, and COX-2 mRNA expression was significantly increased in the EX group compared to that in the CON group (p’s<0.05). IL-1β and COX-2 mRNA expression was significantly increased in the TNBS group compared to that in the 50%EtoH CON group (p’s<0.05).


Conclusion: Thus, inflammatory cytokine IL-1β and COX-2 expression in the small intestine and colon was increased in both high-intensity swimming exercise and IBD models. However, TNF-α was increased only in the swimming exercise model. Further research is required to confirm these observations and establish swimming exercise regimes appropriate for patients with IBD.

Abstract 72 | pdf Downloads 57

References

1. Nieman DC, Henson DA, Gross SJ, et al. Quercetin re-duces illness but not immune perturbations after intensive exercise. Med Sci Sports Exercise 2007;39(9):1561–69.
2. Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 2011;17:6–63.
3. Szalai Z, Szasz A, Nagy I, et al. Anti-inflammatory ef-fect of recreational exercise in TNBS-induced colitis in rats: role of NOS/HO/MPO system. Oxidat Med Cell Longev 2014;2014:925981.
4. Simpson RJ, Kunz H, Agha N, et al. Exercise and the regulation of immune functions. Prog Molec Biol Transl Sci 2015;135:355–80.
5. Cohen DC, Winstanley A, Englegow A, et al. Marathon-induced ischemic colitis: why running is not always good for you. Am J Emerg Med 2009;27(2):255.e5–7.
6. Gezqinci-oktayoglu S, Orhan N, Bolkent S. Prosta-glandin-E1 has a protective effect on renal ischemia/reperfusion-induced oxidative stress and inflammation mediated gastric damage in rats. Internat Immunophar-macol 2016;36:142–50.
7. Moreira NM, Santos FD, Toledo MJ, et al. Moderate physical exercise reduces parasitaemia and protects colonic myenteric neurons in mice infected with Trypa-nosoma cruzi. Int J Exp Pathol 2013;94(6):426–35.
8. Bilski J, Brzozowsik B, Mazur-bialy A, et al. The role of physical exercise in inflammatory bowel disease. BioMed Res Internat 2014;2014:429031
9. Jang HJ, Choi MH, Eun CS, et al. Clinical usefulness of double balloon enteroscopy in suspected Crohn’s disease: the KASID multi-center trial. Hepato-gastroenterology 2014;61(133):1292–96.
10. Koutroubakis I, Manousos ON, Meuwissen SG, et al. Environmental risk factors in inflammatory bowel disease. Hepato-gastroenterology 1996;43(8):381–93.
11. Herrlinger KR, Diculscu M, Fellermann K, et al. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. J Crohn’s Colitis 2013;7(8):636–43.
12. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gas-troenterology 1994;106(2):533–9.
13. Khanna R, Feagan BG. Emerging Therapies for inflamma tory bowel disease. Digest Dis 2016;34(Suppl 1):67–73 14. Voronov E, Apte RN. IL-1 in colon inflammation, colon carcinogenesis and invasiveness of colon cancer. Cancer
Microenviron 2015;8(3):187–200.
15. Gudis K, Sakamoto C. The role of cyclooxygenase in
gastric mucosal protection. Digest Dis Sci 2005;50 (Suppl 1):S16–23.
16. Singh S, Dulai PS, Zarrinpar A, et al. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol 2016;14(2):110–21.
17. Bilski J, Maxur-bialy A, Brzozowski B, et al. Can ex-ercise affect the course of inflammatory bowel disease. Exp Clin Evid Pharmacol Rep 2016;68(4):827–36.
18. Chea J, Yang HI, Kim B, et al. Inflammatory bowel disease Patients’ participation, attitude and preferences toward exercise. Int J Sports Med 2016;37(8):665–70.
19. Cook MD, Martin SA, Williams C, et al. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav Immun 2013;33:46–56.
20. Geng X, Xue J. Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease. Pakistan J Med Sci 2016;32(5):1164–8.
21. Cullen T, Thomas AW, Webb R, et al. Interleukin-6 and associated cytokine responses to an acute bout of high-intensity interval exercise: the effect of exercise intensity and volume. Appl Physiol Nutrit Metabol 2016;41(8):803–8.
22. Morinoto K, Ohta K, Yachie A, et al. Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal disease. Kidney Int 2001;60(5):1858–66.
23. Kvernmo H, Olsen JO, Osterud B. Changes in blood cell response following strenuous physical exercise. Eur J Appl Physiol 1992;64(4):318–22.
24. Pervaiz N, Hoffman-goetz I. Immune cell inflammatory cytokine responses differ between central and systemic compartments in response to acute exercise in mice. Exer Immunol Rev 2012;18:142–57.
25. Scott JP, Sale C, Greeves JP, et al. Cytokine response to acute runing in recreationally-active and endurance-trained men. Eur JAppl Physiol 2013;113(7):1871–82.
26. Wang J, Zhao D, Li J, et al. The impact of water-floating and high-intensity exercise on rat’s HPA axis and inter-leukins concentrations. Acta Physiologica Hungarica 2012;99(3):261–7.
27. Lee HJ, Choi SC, Lee MH, et al. Increased expression of MIP-3alpha/CCL20 in peripheral blood mononuclear cells from patients with ulcerative colitis and its down-regulation by sulfasalazine and glucocorticoid treatment. Inflam Bowel Dis 2005;11(12):1070–9.
28. Krenke K, Peradzynska J, Lange J, et al. Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel disease. Pediatr Pulmonol 2014;49(12):1190–5.
29. Li L, Liu Z, Yang X, et al. Bioluminescence imaging for IL-1b expression in experimental colitis. J Inflam-mat 2013;10:16.
30. Abdallah HH, Freund JN, Reimund JM, et al. Enter-opathogenic e. coli sustains iodoacetamide-induced ulerative dolitis-like colitis in rats: modulation of IL-1 β, IL-6, TNF-α, COX-2, and apoptosis. J Bio Regulat Homeost Agents 2012;26(3):515–26.